TAMARA CLEMETSON: Open Payments
NPI 1891888582 · PARK RIVER, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$554 in 28 payments from 13 companies in 2025. Trend: 2023 $718 · 2024 $731 · 2025 $554
Food & beverage: $554
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 10 | $179 |
| Phathom Pharmaceuticals, Inc. | 3 | $78 |
| Astellas Pharma US Inc | 2 | $45 |
| PFIZER INC. | 2 | $45 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $38 |
| Neurocrine BioSciences, Inc. | 2 | $31 |
| Mallinckrodt Hospital Products Inc. | 1 | $28 |
| ABBVIE INC. | 1 | $23 |
| Verona Pharma, Inc. | 1 | $18 |
| Boston Scientific Corporation | 1 | $18 |
Products named: EVENITY, VOQUEZNA, OTEZLA, Veozah, ELIQUIS, CAPLYTA, INGREZZA, ACTHAR.
Industry payments across ND — which companies pay providers there.
